1. Home
  2. FBRX vs IVR Comparison

FBRX vs IVR Comparison

Compare FBRX & IVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forte Biosciences Inc.

FBRX

Forte Biosciences Inc.

HOLD

Current Price

$76.52

Market Cap

899.4M

Sector

Health Care

ML Signal

HOLD

Logo INVESCO MORTGAGE CAPITAL INC

IVR

INVESCO MORTGAGE CAPITAL INC

HOLD

Current Price

$7.39

Market Cap

732.4M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBRX
IVR
Founded
N/A
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
899.4M
732.4M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
FBRX
IVR
Price
$76.52
$7.39
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$67.00
$8.25
AVG Volume (30 Days)
1.9M
2.6M
Earning Date
05-14-2026
04-30-2026
Dividend Yield
N/A
17.80%
EPS Growth
61.30
N/A
EPS
N/A
N/A
Revenue
$36,000.00
N/A
Revenue This Year
N/A
$150.63
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$6.63
Revenue Growth
N/A
N/A
52 Week Low
$9.25
$7.10
52 Week High
$76.68
$9.50

Technical Indicators

Market Signals
Indicator
FBRX
IVR
Relative Strength Index (RSI) 85.36 32.50
Support Level $24.72 $7.13
Resistance Level N/A $7.93
Average True Range (ATR) 4.60 0.16
MACD 3.29 -0.06
Stochastic Oscillator 99.54 4.82

Price Performance

Historical Comparison
FBRX
IVR

About FBRX Forte Biosciences Inc.

Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.

About IVR INVESCO MORTGAGE CAPITAL INC

Invesco Mortgage Capital Inc is a REIT that invests, finances, and manages residential and commercial mortgage-backed securities and mortgage loans. The company's portfolio consists of residential mortgage-backed securities (RMBS) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association, or a federally chartered corporation such as the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation; Commercial mortgage-backed securities (CMBS) that are not guaranteed by a U.S. government agency or a federally chartered corporation; RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation; and other real estate-related financing arrangements.

Share on Social Networks: